XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Revenue $ 25,235,000 $ 44,383,000
Costs and expenses:    
Cost of revenue 3,451,000 4,582,000
Research and development 4,624,000 8,881,000
Sales and marketing 20,994,000 34,918,000
General and administrative 23,037,000 28,070,000
Total costs and expenses 52,106,000 76,451,000
Loss from operations (26,871,000) (32,068,000)
Interest income (expense), net 112,000 (3,494,000)
Change in fair value of common stock warrant liabilities 9,000 (1,000)
Other income, net 65,000 39,000
Loss before income taxes (26,685,000) (35,524,000)
Provision for income taxes 38,000.0 69,000.0
Net loss $ (26,723,000) $ (35,593,000)
Net loss per share attributable to common stockholders:    
Basic (in dollars per share) $ (1.45) $ (1.70)
Diluted (in dollars per share) $ (1.45) $ (1.70)
Weighted average shares outstanding:    
Basic (in shares) 18,461,221 20,883,293
Diluted (in shares) 18,461,221 20,883,293
Other comprehensive income    
Change in unrealized gain on available-for-sale investments, net of tax $ 6,000 $ 997,000
Total other comprehensive income 6,000 997,000
Total comprehensive loss $ (26,717,000) $ (34,596,000)